Cingulate Inc
NASDAQ:CING
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cingulate Inc
NASDAQ:CING
|
US |
|
Tootsie Roll Industries Inc
NYSE:TR
|
US |
|
Bubs Australia Ltd
ASX:BUB
|
AU |
|
E
|
EnSync Inc
OTC:ESNC
|
US |
|
Broo Ltd
ASX:BEE
|
AU |
|
CH Offshore Ltd
SGX:C13
|
SG |
|
Harris Technology Group Ltd
ASX:HT8
|
AU |
|
D
|
Deluxe Corp
XMUN:DL8
|
US |
|
P
|
Procook Group PLC
LSE:PROC
|
UK |
|
S
|
Satellos Bioscience Inc
OTC:MSCLF
|
CA |
|
Maison Antoine Baud SA
PAR:MLMAB
|
FR |
|
A
|
Avient Corp
XMUN:PY9
|
US |
|
Alkermes Plc
NASDAQ:ALKS
|
IE |
|
Cooper Energy Ltd
ASX:COE
|
AU |
|
American Overseas Group Ltd
OTC:AOREF
|
BM |
|
B
|
BayCom Corp
NASDAQ:BCML
|
US |
|
W
|
Wintest Corp
TSE:6721
|
JP |
Bankruptcy Probability
Cingulate Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cingulate Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cingulate Inc
NASDAQ:CING
|
73.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
286.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cingulate Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cingulate Inc has total debt of 6.1m USD. This includes both short-term (6.1m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
